Edition:
United States

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

11.40USD
22 Feb 2019
Change (% chg)

$0.31 (+2.80%)
Prev Close
$11.09
Open
$11.10
Day's High
$11.59
Day's Low
$11.10
Volume
338,850
Avg. Vol
486,506
52-wk High
$19.97
52-wk Low
$9.14

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.19 December 23 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 2 2 1
(3) HOLD 3 1 1 2
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.80 2.40 2.40 2.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2 70.40 72.00 68.80 75.32
Quarter Ending Jun-19 2 75.25 76.20 74.30 85.60
Year Ending Dec-19 5 298.30 313.90 288.23 332.26
Earnings (per share)
Quarter Ending Mar-19 1 0.19 0.19 0.19 0.32
Quarter Ending Jun-19 1 0.21 0.21 0.21 0.39
Year Ending Dec-19 4 0.81 0.94 0.65 1.33
LT Growth Rate (%) 1 -11.90 -11.90 -11.90 71.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 67.41 64.44 2.97 4.40
Quarter Ending Jun-18 68.49 62.31 6.18 9.03
Quarter Ending Mar-18 58.18 57.66 0.52 0.90
Quarter Ending Dec-17 53.71 53.28 0.43 0.80
Quarter Ending Sep-17 42.46 42.76 0.30 0.71
Earnings (per share)
Quarter Ending Sep-18 0.18 0.14 0.04 22.22
Quarter Ending Jun-18 0.24 0.20 0.04 16.67
Quarter Ending Mar-18 0.16 0.19 0.03 16.35
Quarter Ending Dec-17 0.18 0.17 0.01 6.85
Quarter Ending Sep-17 0.14 0.11 0.03 21.43

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 70.40 70.40 77.30 77.30 75.32
Quarter Ending Jun-19 75.25 75.25 83.10 83.10 85.60
Year Ending Dec-19 298.30 298.30 320.19 320.19 332.26
Earnings (per share)
Quarter Ending Mar-19 0.19 0.19 0.23 0.23 0.32
Quarter Ending Jun-19 0.21 0.21 0.25 0.25 0.39
Year Ending Dec-19 0.81 0.81 1.07 1.07 1.33

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 1
Quarter Ending Jun-19 0 0 0 1
Year Ending Dec-19 0 0 0 4
Earnings
Quarter Ending Mar-19 0 0 0 1
Quarter Ending Jun-19 0 0 0 1
Year Ending Dec-19 0 0 0 2